Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line
about
SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanismsSorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cellsA human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line.Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formationHuman immunodeficiency virus type 1 infection and replication in normal human oral keratinocytesHuman immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell lineNeutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.Thermotropic behavior of galactosylceramides with cis-monoenoic fatty acyl chains.Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates.Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8.Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection.
P2860
Q28368122-992DCB4F-15E9-41DB-843E-94066B2CC1E6Q28378807-CB892F7A-2B2C-4540-A182-F34468EBDF84Q33796739-BB90FD44-F02A-4EAC-A0CA-D098A2BE0B44Q34649015-75056FF3-29CB-45A0-8636-9A8E710184BBQ34745651-DF5EB914-AB87-4D36-9A4F-6D0D55651452Q35851603-4F3B6D31-B15D-4C62-A73D-3E65125B7B2FQ35898116-91000C49-E565-4BE3-9027-38754F473F20Q39038416-49FF597D-01B3-4890-95EC-481224F295A0Q39876649-F7BDBDEC-B097-4275-8365-D027A8C75081Q39878288-E33A2B5E-2819-4815-97EF-47598792472AQ44412688-D84B83EE-AFDA-4EE8-8990-41EFC31772EB
P2860
Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@ast
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@en
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@nl
type
label
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@ast
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@en
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@nl
prefLabel
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@ast
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@en
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@nl
P2093
P2860
P1433
P1476
Synthetic multimeric peptides ...... e mucosal epithelial cell line
@en
P2093
F Gonzalez-Scarano
S Baghdiguian
P2860
P304
P407
P577
1995-01-01T00:00:00Z